Nicholas M. Pachuda
Directeur/Membre du Conseil chez Biorez, Inc.
Profil
Nicholas M.
Pachuda is an Independent Director at Biorez, Inc. and a Director at Gid Bio Inc. He was previously a Vice President-Medical Education at Small Bone Innovations, Inc. He obtained an undergraduate degree from the University of Pittsburgh.
Postes actifs de Nicholas M. Pachuda
| Sociétés | Poste | Début |
|---|---|---|
Biorez, Inc.
 Biorez, Inc. Medical SpecialtiesHealth Technology BioRez, Inc. engages in the design and development of resorbable polymer scaffold technology. The firm offers a device that is suited for tendon, ligament, and other soft tissue injuries. The company was founded by Cato T. Laurencin and Joseph W. Reilly in 2008 and is headquartered in New Haven, CT. | Directeur/Membre du Conseil | 17/03/2021 |
Gid Bio Inc.
 Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Directeur/Membre du Conseil | - |
Anciens postes connus de Nicholas M. Pachuda
| Sociétés | Poste | Fin |
|---|---|---|
Small Bone Innovations, Inc.
 Small Bone Innovations, Inc. Medical SpecialtiesHealth Technology Small Bone Innovations, Inc. develops and markets implants for the small bones and joints. It offers Star Ankle, A3 fusion nail, Auto fix stainless steel, Stafix, mini rail system, Fusifix, Silicon pip, Stability sigmoid notch, Rhead, Uni-Elbow radio capitellum and Autofix. The company was founded by Anthony G. Viscogliosi, John L. Viscogliosi, and Marc R. Viscogliosi in May 2004 and is headquartered in Morrisville, PA. | Corporate Officer/Principal | - |
Formation de Nicholas M. Pachuda
| University of Pittsburgh | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Small Bone Innovations, Inc.
Small Bone Innovations, Inc. Medical SpecialtiesHealth Technology Small Bone Innovations, Inc. develops and markets implants for the small bones and joints. It offers Star Ankle, A3 fusion nail, Auto fix stainless steel, Stafix, mini rail system, Fusifix, Silicon pip, Stability sigmoid notch, Rhead, Uni-Elbow radio capitellum and Autofix. The company was founded by Anthony G. Viscogliosi, John L. Viscogliosi, and Marc R. Viscogliosi in May 2004 and is headquartered in Morrisville, PA. | Health Technology |
Biorez, Inc.
Biorez, Inc. Medical SpecialtiesHealth Technology BioRez, Inc. engages in the design and development of resorbable polymer scaffold technology. The firm offers a device that is suited for tendon, ligament, and other soft tissue injuries. The company was founded by Cato T. Laurencin and Joseph W. Reilly in 2008 and is headquartered in New Haven, CT. | Health Technology |
Gid Bio Inc.
Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Health Services |